Camber Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-900,000
Closed -$43M 41
2023
Q4
$43M Buy
+900,000
New +$43M 1.1% 19